Lv1
30 积分 2024-01-08 加入
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT): a multicentre, randomised, placebo-controlled, phase 3 trial
4小时前
已完结
Real-life effectiveness of rituximab in different subsets of idiopathic inflammatory myopathies
3天前
求助中
Methotrexate osteopathy: an increasingly recognised condition manageable only through methotrexate discontinuation
6个月前
已关闭
A glucocorticoid-free era for polymyalgia rheumatica: are we on the brink of change?
6个月前
已关闭
Methotrexate osteopathy: an increasingly recognised condition manageable only through methotrexate discontinuation
6个月前
已关闭
Current understanding and management of cardiovascular involvement in rheumatic immune-mediated inflammatory diseases
6个月前
已完结
An update on autoantibodies in the idiopathic inflammatory myopathies
6个月前
已完结
Abatacept for myositis
6个月前
已完结
Autosomal Recessive Polycystic Kidney Disease: Diagnosis, Prognosis, and Management
10个月前
已关闭
Biomarkers of Kidney Disease Progression in ADPKD
10个月前
已完结
皖公网安备34019202002308
